Increasing adoption of radiation emitting diagnosis tools such as CT scans and MRI by hospitals, ambulatory care centers, and others is expected to increase the demand for dosimeters among healthcare professionals operating these tools, which in turn is driving the global dosimeters market growth. For instance, according to the data published by the Organization for Economic Co-operation and Development (OECD), in the U.S., the total unit of Magnetic Resonance Imaging (MRI) in hospital and ambulatory care centers in 2015, were around 39.0 per 1,000,000 inhabitants, which increased from 31.5 per 1,000,000 population in 2010.
Click To Continue Reading On Dosimeters Market
Furthermore, recent past has witnessed high adoption of nuclear medicines and radiotherapy for diagnosis of different types of disease such as cancer and some neurological disorders. Hence, increasing prevalence of cancer is expected to increase demand for radiotherapy and nuclear medicines, which in turn is expected to increase demand for dosimeters for healthcare professional working with these radiation emitting substances. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.
Key players are engaged in launching novel dosimeters in the market, which is expected to drive the global dosimeters market growth. For instance, in April 2018, Tracerco, part of the FTSE100 company, Johnson Matthey Plc. launched two Personal Electronic Dosimeters (PEDs) – the PED-ER and PED-ER+. In 2013, Polimaster Ltd., launched a new Radiation Detector POLISMART II PM1904. This new dosimeter work as a non-wearable gadget, which is connected to iPhone via dock-port and radiation is measured with the help of application in phone.
Download The PDF Brochure: